Erlotinib (Tarceva®) induced severe exanthema

被引：0
|
作者：
Fernandez-Guarino, M. [1 ]
Lopez, P. Garrido
Gonzalez-Garcia, C.
Jaen, P.
机构：
[1] Hosp Ramon & Cajal, Serv Dermatol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Oncol, E-28034 Madrid, Spain
[3] Hosp Ramon & Cajal, Serv Anat Patol, E-28034 Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2007年 / 207卷 / 08期
关键词：
D O I：
10.1157/13108767
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：422 / 423
页数：2
相关论文
共 50 条
  • [1] Tarceva - Erlotinib tablets
    不详
    FORMULARY, 2005, 40 (12) : 425 - 425
  • [2] Hand-foot syndrome induced by erlotinib (Tarceva)
    Cho, Yong-Sun
    Kim, Joo-Ik
    Hwang, Su-Ran
    Song, Ki-Hun
    Nam, Kyung-Hwa
    Park, Jin
    Yun, Seok-Kweon
    Kim, Han-Uk
    JOURNAL OF DERMATOLOGY, 2012, 39 : 272 - 272
  • [3] Hand-foot syndrome induced by erlotinib (TarcevaⓇ)
    Cho, Yong-Sun
    Park, Jin
    Kim, Ju-Ik
    Nam, Kyung-Hwa
    Yun, Seok-Kweon
    Kim, Han-Uk
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (03) : E190 - E192
  • [4] Preclinical studies with erlotinib (Tarceva)
    Akita, RW
    Sliwkowski, MX
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 15 - 24
  • [5] Generalized xerotic dermatitis with neutrophilic spongiosis induced by erlotinib (Tarceva®)
    Luebbe, J.
    Masouye, I.
    Dietrich, P. -Y.
    DERMATOLOGY, 2008, 216 (03) : 247 - 249
  • [6] A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva®)
    Marquez, Gemma
    Herrera-Acosta, Enrique
    Vidal, Isabel
    Galvany, Loida
    Iglesias, Maribel
    Umbert, Pablo
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (01) : 97 - 98
  • [7] Pathogenesis and management of Erlotinib (Tarceva®) -: induced cutaneous side effects
    Gerber, P. A.
    Enderlein, E.
    Ansari, P.
    Homey, B.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 243 - 244
  • [8] ERLOTINIB (TARCEVA®) USE IN A NORTH OF ENGLAND POPULATION
    Williamson, Steve
    Polwart, Calum
    Horsley, William
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (07) : O42 - O43
  • [9] Erlotinib (Tarceva): An update on the clinical trial program
    Herbst, RS
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 34 - 46
  • [10] Outcomes with erlotinib (Tarceva®) in a Yorkshire cancer centre
    O'Toole, L.
    Bond, M.
    Snee, M.
    LUNG CANCER, 2007, 57 : S7 - S7
12345